Market Overview & Key Highlights: Nirmala Sitharaman has identified China's constraints on Indian exports as a crucial hindrance to trade advancement. The finance minister reported a staggering trade deficit exceeding $100 billion with China this year, even with improved diplomatic relations. She noted that non-tariff barriers obstruct Indian products, especially generic medicines, from entering China. Industry Implications & Expert Analysis: Financial analysts and market observers note that this development will introduce substantial shifts across the ecosystem. Stakeholders are closely tracking operational parameters and compliance requirements. Future Outlook: As markets adapt, businesses and professionals are advised to maintain strategic agility. Comprehensive updates will continue to be tracked by our editorial desk as the situation unfolds.